| __timestamp | Soleno Therapeutics, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 1499100000 |
| Thursday, January 1, 2015 | 7878291 | 1923500000 |
| Friday, January 1, 2016 | 8366794 | 2351400000 |
| Sunday, January 1, 2017 | 6610381 | 2564000000 |
| Monday, January 1, 2018 | 6556000 | 2397300000 |
| Tuesday, January 1, 2019 | 6930000 | 2503400000 |
| Wednesday, January 1, 2020 | 8758000 | 3344600000 |
| Friday, January 1, 2021 | 10806000 | 4529200000 |
| Saturday, January 1, 2022 | 9844000 | 4179100000 |
| Sunday, January 1, 2023 | 13481000 | 4650100000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viatris Inc. and Soleno Therapeutics, Inc. from 2014 to 2023. Over this period, Viatris Inc. consistently outpaced Soleno Therapeutics, Inc. in SG&A spending, with expenses peaking at approximately $4.65 billion in 2023, a staggering 300% increase from 2014. In contrast, Soleno Therapeutics, Inc. saw a more modest rise, with expenses growing by about 360% to $13.48 million in the same year. This disparity highlights the scale and operational differences between the two companies. While Viatris Inc. operates on a global scale, Soleno Therapeutics, Inc. remains more niche-focused. These insights underscore the importance of strategic financial management in the pharmaceutical industry.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Viatris Inc. and Insmed Incorporated
Who Optimizes SG&A Costs Better? Viatris Inc. or Madrigal Pharmaceuticals, Inc.
Viatris Inc. vs Exelixis, Inc.: SG&A Expense Trends
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Viatris Inc. and Evotec SE
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Soleno Therapeutics, Inc. vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights